The anxiolytic CRF1 antagonist DMP696 fails to function as a discriminative stimulus and does not substitute for chlordiazepoxide in rats

Psychopharmacology

Volumn 166, Issue 4, 2003, Pages 408-415

  Lelas, Snjezana ^a   Zeller, Kim L ^a   Ward, Kathryn A ^a   McElroy, John F ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

Chlordiazepoxide; Defensive withdrawal; DMP696; Drug discrimination; Rats

Indexed keywords

8 (2,4 DICHLOROPHENYL) 4 [2 METHOXY 1 (METHOXYMETHYL)ETHYLAMINO] 2,7 DIMETHYLPYRAZOLO[1,5 A][1,3,5]TRIAZINE; BENZODIAZEPINE; BUSPIRONE; CHLORDIAZEPOXIDE; DIAZEPAM; THIOPENTAL;

ACUTE DRUG ADMINISTRATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DEFENSIVE BEHAVIOR; DISCRIMINATIVE STIMULUS; DRUG DISCRIMINATION; DRUG MECHANISM; DRUG SUBSTITUTION; LATENT PERIOD; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; TRANQUILIZING ACTIVITY; WITHDRAWAL REFLEX;

EID: 0037393153     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-002-1331-8     Document Type: Article

References (46)

1. Barbone F, McMahon AD, Davey PG, Morris AD, Reid IC, McDevitt DC, MacDonald TM (1998) Association of road-traffic accidents with benzodiazepine use. Lancet 352:1331-1336
2. Carter RB, Leander JD (1982) Discriminative stimulus properties of naloxone. Psychopharmacology 77:305-308
3. Ciraulo DA, Sands BF, Shader RI (1988) Critical review of liability for benzodiazepine abuse among alcoholics. Am J Psychiatry 145:1501-1506
4. Colpaert FC, Desmedt LKC, Janssen PAJ (1976) Discriminative stimulus properties of benzodiazepines, barbiturates and pharmacologically related drugs: relation to some intrinsic and anticonvulsant effects. Eur J Pharmacol 37:113-123
5. Costa E, Guidotti A (1996) Benzodiazepines on trial: a research strategy for their rehabilitation. Trends Pharmacol Sci 17:192-200
6. D'Mello GD, Stolerman IP (1977) Comparison of the discriminative stimulus properties of cocaine and amphetamine in rats. Br J Pharmacol 61:415-422
7. Dumont RL (1988) Abuse of benzodiazepines the problems and the solutions. A report of a Committee of the Institute for Behavior and Health, Inc. Am J Drug Alcohol Abuse 14:1-69
8. France CP, Woods JH (1988) Acute supersensitivity to the discriminative stimulus effects of naltrexone in pigeons. J Pharmacol Exp Ther 244:599-605
9. Frey JM, Mintzer MZ, Rush CR, Griffiths RR (1998) Buspirone is differentiated from diazepam in humans using a three-response drug discrimination procedure. Psychopharmacology 138:16-26
10. Gerak LR, France CP (1999) Discriminative stimulus effects of flumazenil in untreated and in diazepam-treated rhesus monkeys. Psychopharmacology 146:252-261
11. Gobbi M, Cavanus S, Miari A, Mennini T (1991) Effect of acute and chronic administration of buspirone on serotonin and benzodiazepine receptor subtypes in the rat brain: an autoradiographic study. Neuropharmacology 30:313-321
12. Griebel G, Perrault G, Sanger DJ (1998) Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone. Psychopharmacology 138:55-66
13. Griffiths RR, Lamb RJ, Sannerud CA, Ator NA, Brady JV (1991) Self-injection of barbiturates, benzodiazepines and other sedative-anxiolytics in baboons. Psychopharmacology 103:154-161
14. He L, Gilligan PJ, Zaczek R, Fitzgerald LW, McElroy J, Shen H-SL, Saye JA, Kalin NH, Shelton S, Christ D, Trainor G, Hartig P (2000) 4-(1,3-Dimethoxyprop-2-ylamino)-2,7-dimethyl-8-(2,4-dichlorophenyl)- pyrazolo[1,5-a]-1,3,5-triazine: a potent, orally bioavailable CRF1 receptor antagonist. J Med Chem 43:449-456
15. Hikichi T, Akiyoshi J, Yamamoto Y, Tsutsumi T, Isogawa K, Nagayama H (2000) Suppression of conditioned fear by administration of CRF receptor antagonist CP-154,526. Pharmacopsychiatry 33:189-193
16. Hill G, Zaczek R, Li Y-W (2001) Corticotropin releasing factor type-1 receptor occupancy of DMP696 in rat brain: ex vivo binding autoradiography. Soc Neurosci Abstr 27:149.14
17. Holder HD (1992) Effects of alcohol, alone and in combination with medications. Prevention Research Center, Walnut Creek, Calif.
18. Iguchi MY, Griffiths RR, Bickel WK et al. (1988) Relative abuse liability of benzodiazepine in methadone-maintained populations in three cities. In: Harris LS (ed) Problems of drug dependence: proceedings of the 50th Annual Scientific Meeting, The Committee on Problems of Drug Dependence Inc., US Department of Health and Human Services [DHHS Publication Number (ADM) 89-1605], Rockville, Md.
19. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council (1996) Guide for the care and use of laboratory animals, 7th edn. National Academy Press, Washington, D.C.
20. Kamien JB, Woolverton WL (1989) Failure of SCH 23390 to function as a discriminative stimulus in rats. Pharmacol Biochem Behav 34:337-340
21. Keck ME, Welt T, Wigger A, Renner U, Engelmann M, Holsboer F, Landgraf R (2001) The anxiolytic effect of the CRH(1) receptor antagonist R121919 depends on innate emotionality in rats. Eur J Neurosci 13:373-380
22. Kehne JH, Coverdale S, McCloskey TC, Hoffman DC, Cassella JV (2000) Effects of CRF1 receptor antagonist, CP 154,526, in the separation-induced vocalization anxiolytic test in rat pups. Neuropharmacology 39:1357-1367
23. Kirk RE (1968) Experimental design: procedures for the behavioral sciences. Brooks/Cole, Belmont, Calif.
24. Knisely JS, Rees DC, Balster RL (1990) Discriminative stimulus properties of toluene in the rat. Neurotoxicol Teratol 12:129-133
25. Kuhn DM, White FJ, Appel JB (1978) The discriminative stimulus properties of LSD: mechanisms of action. Neuropharmacology 17:257-263
26. Ladewig D (1983) Abuse of benzodiazepines in western European society incidence and prevalence, motives, drug acquisition. Pharmacopsychiatria 16:103-106
27. Lelas S, Spealman RD, Rowlett JK (2000) Using behavior to elucidate receptor mechanisms: a review of the discriminative stimulus effects of benzodiazepines. Exp Clin Psychopharmacol 8:294-311
28. Lundkvist J, Chai Z, Teheranian R, Hasanvan H, Bartfai T, Jenck F, Widmer U, Moreau J-L (1996) A non peptidic corticotropin releasing factor receptor antagonist attenuates fever and exhibits anxiolytic-like activity. Eur J Pharmacol 309:195-200
29. Maciag CM, Dent G, Gilligan P, He L, Dowling K, Ko T, Levine S, Smith MA (2002) Effects of a non-peptide CRF antagonist (DMP696) on the behavioral and endocrine sequelae of maternal separation. Neuropsychopharmacology 26:574-582
30. Mansbach RS, Barrett JE (1987) Discriminative stimulus properties of buspirone in the pigeon. J Pharmacol Exp Ther 240:364-369
31. McElroy JF, Stimmel JJ, O'Donnell JM (1989) Discriminative stimulus properties of haloperidol. Drug Dev Res 18:47-55
32. McElroy JF, Ward KA, Zeller KL, Gilligan PJ, He L, Lelas S (2002) The non-peptide CRF1 receptor antagonist DMP696 produces anxiolytic effects and inhibits the hypothalamic-pituitary-adrenal axis without sedation or ataxia. Psychopharmacology 165:86-92
33. Negus SS, Gatch MB, Mello NK (1998) Discriminative stimulus effects of a cocaine/heroin "speedball" combination in rhesus monkeys. J Pharmacol Exp Ther 285:1123-1136
34. Olivier B, Broersen LM, Slangen JL (2002) 5-HT3 receptor ligands lack discriminative stimulus properties. Prog Neuropsychopharmacol Biol Psychiatry 26:463-471
35. Platt DM, Rowlett JK, Spealman RD (2001) Discriminative stimulus effects of intravenous heroin and its metabolites in rhesus monkeys: opioid and dopaminergic mechanisms. J Pharmacol Exp Ther 299:760-767
36. Preston KL, Bigelow GE (1991) Subjective and discriminative effects of drugs. Behav Pharmacol 2:293-313
37. Rijnders HJ, Slangen JL (1993) The discriminative stimulus properties of buspirone involve dopamine-2 receptor antagonist activity. Psychopharmacology 111:55-61
38. Sanger DJ, Joly D, Zivkovic B (1985) Behavioral effects of nonbenzodiazepine anxiolytic drugs: a comparison of CGS and zopiclone with chlordiazepoxide. J Pharmacol Exp Ther 232:831-837
39. Sellers EM, Schneiderman JF, Romach MK, Kaplan HL, Somer GR (1992) Comparative drug effects and abuse liability of lorazepam, buspirone, and secobarbital in nondependent subjects. J Clin Psychopharmacol 12:79-85
40. Spealman RD (1985) Discriminative-stimulus effects of midazolam in squirrel monkeys: comparison with other drugs and antagonism by Ro 15-1788. J Pharmacol Exp Ther 235:456-462
41. Takahashi L (2001) Role of CRF1 and CRF2 receptors in fear and anxiety. Neurosci Biobehav Rev 25:627-636
42. Takahashi LK, Kalin NH, Vanden Burgt JA, Sherman JE (1989) Corticotropin-releasing factor modulates defensive-withdrawal and exploratory behavior in rats. Behav Neurosci 103:648-654
43. Wettstein JG, Gauthier B (1992) Discriminative stimulus effects of alprazolam and diazepam: generalization to benzodiazepines, antidepressants and buspirone. Behav Pharmacol 3:229-237
44. Winter JC (1975) The effects of 2,5-dimethoxy-4-methylamphetamine (DOM), 2,5-dimethoxy-4-ethylamphetamine (DOET), d-amphetamine, and cocaine in rats trained with mescaline as a discriminative stimulus. Psychopharmacologia 44:29-32
45. York JL (1978) A comparison of the discriminative stimulus effects of ethanol, barbital, and phenobarbital in rats. Psychopharmacology 60:19-23
46. Zobel AW, Nickel T, Kunzel HE, Ackl N, Sonntag A, Ising M, Holsboer F (2000) Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated. J Psychiatr Res 34:171-181